Applications Sought to Build Uterine Fibroids Registry for Treatment Research
The federal government shutdown has not affected the Monday, Dec. 16 due date for funding applications for our project to improve treatment for uterine fibroids, a joint effort with the U.S. Agency for Healthcare Research and Quality (AHRQ). We will commit up to $20 million over five years to an awardee to develop a large registry of women treated for uterine fibroids and conduct comparative studies of therapies using registry data. AHRQ is administering the application process through a Request for Applications (RFA). Letters of intent, though not required, may be submitted to AHRQ by Friday, Nov. 15.